JSMC
ZSAN

Jess S. Morgan & Co’s Zosano Pharma Corporation ZSAN Stock Holding History

Jess S. Morgan & Co’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,143
Closed -$19K – 48
2021
Q4 		$19K Buy
+1,143
New +$24.1K 0.01% 46
2020
Q4 		– Sell
-33,501
Closed -$1.9M – 42
2020
Q3 		$1.9M Buy
+33,501
New +$1.56M 1.9% 32

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jess S. Morgan & Co's ZSAN Position: Q1 2022 in Review

Jess S. Morgan & Co sold out of Zosano Pharma Corporation (ZSAN) in Q1 2022, closing a stake of 1,143 shares — an estimated $19K sold.

Jess S. Morgan & Co first reported a position in ZSAN in Q3 2020 and held it in 2 quarters. The position peaked at $1.9M in Q3 2020. 30 funds tracked by Wall St. Rank hold ZSAN as of Q1 2022.

  • Jess S. Morgan & Co reported no remaining Zosano Pharma Corporation position as of Q1 2022 after selling out during the quarter.
  • Jess S. Morgan & Co sold 1,143 Zosano Pharma Corporation shares in Q1 2022, an estimated $19K.
  • Jess S. Morgan & Co first reported a position in Zosano Pharma Corporation in Q3 2020 and held it in 2 quarters.
  • Jess S. Morgan & Co's Zosano Pharma Corporation position peaked at $1.9M in Q3 2020.
  • 30 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2022.

Based on Jess S. Morgan & Co's 13F filing for Q1 2022, filed 16 May 2022.